nvo market cap by year

Novo Nordisk A-S (NVO) has a market capitalization of $200.1B, based on 4.37B shares at a price of $45.80 (down 2.2% today).

DATECLOSEVOLUMEOUTSTANDINGMARKET CAP
May 2026
$47.08
167,946,282
4,368,825,268
$205,684,293,617.44
April 2026
$42.22
349,802,400
4,368,825,268
$184,451,802,814.96
March 2026
$36.75
423,663,800
4,448,700,000
$163,489,725,000.00
February 2026
$36.13
604,339,600
4,448,700,000
$160,709,732,370.00
January 2026
$57.33
447,951,200
4,448,700,000
$255,032,849,250.00
December 2025
$49.08
349,722,400
4,447,851,000
$218,300,527,080.00
November 2025
$47.60
458,519,700
4,447,851,000
$211,735,943,789.10
October 2025
$47.71
278,824,400
4,447,851,000
$212,207,860,780.20
September 2025
$53.53
310,264,700
4,446,800,000
$238,023,418,920.00
August 2025
$54.46
418,106,900
4,446,800,000
$242,184,289,680.00
July 2025
$44.90
371,108,700
4,446,800,000
$199,655,983,840.00
June 2025
$65.84
186,234,800
4,446,812,000
$292,762,093,556.80
May 2025
$68.20
239,163,700
4,446,812,000
$303,281,472,024.00
April 2025
$63.38
219,470,000
4,446,812,000
$281,860,733,938.80
March 2025
$66.24
148,675,300
4,446,400,000
$294,516,196,800.00
February 2025
$85.10
167,481,000
4,446,400,000
$378,377,079,360.00
January 2025
$79.28
189,740,600
4,446,400,000
$352,498,142,080.00
December 2024
$80.75
170,270,800
4,460,500,000
$360,189,835,500.00
November 2024
$100.26
121,015,600
4,460,500,000
$447,201,701,100.00
October 2024
$105.09
108,317,800
4,460,500,000
$468,765,988,350.00
September 2024
$111.78
78,552,600
4,460,500,000
$498,579,524,300.00
August 2024
$130.64
90,131,500
4,460,500,000
$582,701,878,000.00
July 2024
$124.04
92,171,100
4,460,500,000
$553,288,002,850.00
June 2024
$133.50
69,209,700
4,465,400,000
$596,117,503,800.00
May 2024
$126.52
83,582,700
4,465,400,000
$564,962,854,540.00